New solutions for studying RNA for infectious disease, oncology, and genetic disease research We are excited for the launch of the expanded RNA Library Preparation product portfolio. The new enhancements deliver solutions for studying RNA that provide rapid turn-around time, broad study flexibility and sequencing scalability while delivering exceptional data quality for infectious disease, oncology, and […]
Advanced AI-discovery platform Imagia EVIDENS™ to link analysis of genomic data to patient outcomes for reproducible data-driven precision medicine research MONTRÉAL – Imagia, a leading healthcare AI company that unites healthcare expertise and advanced artificial intelligence technology, and Illumina, a global leader in DNA sequencing and analysis, today announced a partnership to investigate how genomics, clinical data and imaging will […]
Company launches Q Line sequencing portfolio for users in regulated settings Oxford Nanopore today announced its pathway towards providing products for the diagnostics and other regulated markets. Products for customers in regulated environments Q line, launched today, is designed to support users who wish to develop tests based on nanopore sequencing, for deployment in their own environments. The ISO9001-qualified Q […]
Comprehensive Panel Designed to Provide Molecular Characterization of Aggressive Lymphomas TUCSON, Ariz. — HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company whose mission is to advance precision medicine, today announced the pre-launch introduction of its new HTG EdgeSeq Pan B-Cell Lymphoma Panel, which is expected to be commercially available for purchase in kit […]
MGI respects the court’s ruling on Illumina’s request for a preliminary injunction, but we do not agree with this decision and we are evaluating our options including an immediate appeal of this ruling. MGI also looks forward to the final decision on this matter after a full trial on the merits has occurred. In […]
To learn more about Canopy’s data analysis offerings, please browse the Canopy website. St. Louis, MO—Canopy Biosciences, a multi-omic CRO providing NanoString® nCounter® and RNA Seq services to both clinical and research customers, has partnered with Onramp BioInformatics™ to offer their ROSALIND™ interactive data analysis platform for Canopy’s gene expression services. Launched earlier this year, Canopy […]
The team that created STRmix™ – sophisticated forensic software used to resolve mixed DNA profiles previously thought to be too complex to interpret – is launching FaSTR™ DNA, expert forensic software that rapidly analyzes DNA profiles and assigns a Number of Contributors (NoC) estimate. Designed by scientists for scientists, FaSTR™ DNA expedites the analysis of […]
Blue-Ray Biotech Corporation, a professional life science laboratory instrument manufacturer, announced today the upgrade of its award-winning gradient PCR thermal cycler, the TurboCycler 2. Fitted with flexible ramp rate control and adjustable lid temperature designs, the new version of TurboCycler 2 is more suitable than ever for applications such as CRISPR assays and NGS pre-treatments. The ramp […]
Enabling clinical, translational research, population genomics, and biopharma customer markets SAN DIEGO– Illumina, Inc. is enhancing its capabilities to analyze and interpret the data produced by its sequencing systems with the acquisition of BlueBee, a cloud-based software company that provides genomics analysis solutions for research and clinical customers. Based in the Netherlands, BlueBee has developed […]
Tromsø, Norway – Biotec Pharmacon (OSE: BIOTEC) announces it has officially rebranded to ArcticZymes Technologies. As previously announced and decided by the Annual General Meeting, Biotec Pharmacon ASA has formally changed its name to ArcticZymes Technologies ASA. The new name is formally registered with Brønnøysundregistrene and will trade under the new ticker “AZT” over the […]
Pay Invoice
Latest Blogs
-
EU Roadmap Provides Further Impetus for New Approach Methodologies
June 29, 2026 12:56 pm
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
